Harry K. Dupree Stuttgart National Aquaculture Research Center Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
Warmwater Fish Production Research
Therapeutics Evaluation and Registration Research
 

Research Project: STRATEGIES FOR FISH DISEASE CONTROL AND PREVENTION

Location: Harry K. Dupree Stuttgart National Aquaculture Research Center

Title: The Safety of AQUAFLOR (50% Florfenicol; Type A Medicated Article) Administered in feed to sunshine bass (female white bass Morone chrysops × male striped bass M. saxatilis)

Authors
item Bowker, James -
item Straus, David
item Bowman, Molly -
item Carty, Dan -
item Dotson, Miranda -
item Mitchell, Andrew
item Farmer, Bradley

Submitted to: Aquatic Animal Drug Approval Partnership (AADAP)
Publication Type: Research Notes
Publication Acceptance Date: October 18, 2010
Publication Date: November 17, 2010
Citation: Bowker, J.D., Straus, D.L., Bowman, M.P., Carty, D., Dotson, M., Mitchell, A.J., Farmer, B.D. 2010. The Safety of AQUAFLOR (50% Florfenicol; Type A Medicated Article) Administered in feed to sunshine bass (female white bass Morone chrysops × male striped bass M. saxatilis). U.S. Fish & Wildlife Service, Aquatic Animal Drug Approval Partnership, Drug Research Information Bulletin 19. 2 p.

Technical Abstract: Bacterial diseases are a major problem in aquaculture and account for significant losses of fish (Clarke and Scott 1989; Frerichs and Roberts 1989; Bjorndal 1990). Therefore, the use of antimicrobial therapy plays an important role in aquaculture (Klontz 1987; Alderman 1988). Florfenicol (FFC) is a potent, broad-spectrum, antibacterial agent with bacteriostatic and bacteriocidal properties that is active against a variety of Gram-positive and Gram-negative bacteria (Horsberg et al. 1996). AQUAFLOR® is an aquaculture feed premix containing 50% florfenicol (weight-to-weight). Worldwide, AQUAFLOR® has been approved in more than 20 countries (e.g., Norway, Japan, Chile, Canada, and the U.S.) to control mortality in a variety of cultured fishes due to diseases associated with infectious pathogens. In the U.S., the Food and Drug Administration (FDA) has approved AQUAFLOR® for use to control mortality in (1) catfish due to enteric septicemia associated with Edwardsiella ictaluri, (2) freshwater-reared salmonids due to coldwater disease associated with Flavobacterium psychrophilum, and (3) freshwater-reared salmonids due to furunculosis associated with Aeromonas salmonicida (Bowker et al., in press). In the U.S., the only approved treatment regimen is to administer AQUAFLOR® in feed at 10 mg FFC/kg fish body weight/d for 10 consecutive days.

   

 
Project Team
Straus, David - Dave
Beck, Benjamin
 
Publications
   Publications
 
Related National Programs
  Aquaculture (106)
 
Related Projects
   COLLABORATIVE EFFORT TO GAIN FDA-APPROVAL FOR USE OF TRIANGLE BRAND (C) COPPER SULFATE AS AN AQUACULTURE THERAPEUTANT
   METHODS TO CONTROL EGG MORTALITY ASSOCIATED WITH AQUATIC FUNGUS (SAPROLEGNIA SPP.) INFECTING HYBRID STRIPED BASS EGGS
   COLLABORATIVE STUDIES ON THE ACUTE TOXICITY AND EFFECTIVENESS OF PERACETIC ACID COMPOUNDS TO FISH AND AQUATIC DISEASE ORGANISMS
 
 
Last Modified: 06/18/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House